Enfortumab vedotin in FGFR3-mutated advanced urothelial carcinoma Meeting Abstract


Authors: Teo, M. Y.; Ratna, N.; Regazzi, A. M.; Zimmerman, D. E.; McHugh, D. J.; Laccetti, A. L.; Xiao, H.; Lee, C. H.; Aggen, D. H.; Funt, S. A.; Bajorin, D. F.; Iyer, G.; Rosenberg, J. E.
Abstract Title: Enfortumab vedotin in FGFR3-mutated advanced urothelial carcinoma
Meeting Title: 2021 Genitourinary Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 39
Issue: 6 Suppl.
Meeting Dates: 2021 Feb 11-13
Meeting Location: Virtual
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2021-02-20
Language: English
ACCESSION: WOS:000636801500460
DOI: 10.1200/JCO.2021.39.6_suppl.458
PROVIDER: wos
Notes: Meeting Abstract: 458 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Dean Bajorin
    663 Bajorin
  2. Han Xiao
    62 Xiao
  3. Gopakumar Vasudeva Iyer
    358 Iyer
  4. Ashley Regazzi
    93 Regazzi
  5. Jonathan Eric Rosenberg
    524 Rosenberg
  6. Chung-Han   Lee
    157 Lee
  7. Samuel Aaron Funt
    143 Funt
  8. Min Yuen   Teo
    106 Teo
  9. Deaglan Joseph McHugh
    45 McHugh
  10. David Henry Aggen
    60 Aggen
  11. Neha Ratna
    14 Ratna